Approval · Notice of Compliance 10260 · 2009
ALEVE: Notice of Compliance 10260
Issued June 19, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10260
- Date
- June 19, 2009
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
- Therapeutic class
- Analgesic / antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALEVE | Not yet assigned | — |
Medicinal ingredients
- NAPROXEN SODIUM 220 MG per TAB